Atlas Trials

MyLeukoMAP™ Genomic Survival Prediction Assay Pivotal Clinical Study

Clinical trial NCT05258942 · UNKNOWN

Trial details

NCT number
NCT05258942
Sponsor
LeukoLifeDx Inc
Status
UNKNOWN
Study type
OBSERVATIONAL
Heart Failure
Start date
2022-07-01
Primary completion
2023-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.